1. Medtech Insight
  2. >>Policy & Regulation

Philips Asks Health Care Leaders: How Ready Are You For The Global Health Care Challenge?

Major survey shows digital reset, staffing and sustainability dominate agendas in the post-COVID world of shifting health care priorities

 
• By Ashley Yeo

Every year since 2016, Royal Philips has polled health care leaders for their views on trends in the market, providing useful information for the wider medtech industry as it shapes its response to evolving needs. The Future Health Index 2022 shows that industry is finally looking beyond COVID-19.

Digital Consultation
• Source: Alamy

“As we emerge from the pandemic, health care leaders worldwide are embarking on a 'reboot,'” according to Jan Kimpen, chief medical officer of Royal Philips.

Speaking at the release of the company’s Future Health Index (FHI) 2022 report, Kimpen noted that Philips aimed to determine the readiness of health care

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

More from Medtech Insight

Beyond The Bladder: Incontinence Impacts Mental Health

 
• By Brian Bossetta

In recognition of Mental Health Awareness month, Sarah Jenkins, executive director at the National Association for Continence, discussed the mental health issues that often come with incontinence.

AI Rollout Aims To Accelerate FDA’s Product Review Process

 
• By Elizabeth Orr

The FDA plans to implement artificial intelligence in its scientific review process by 30 June, following a successful pilot. The agency hopes the tool will reduce nonproductive tasks for reviewers amid recent staff cuts. A Chief AI Officer will oversee the rollout and integration.

Access To Library Tools Being Restored At US FDA

 
• By Sue Sutter and Derrick Gingery

Agency staff once again have access to the Lexis-Nexis legal and news database, but are still waiting for access to journals and laid off librarians have not been reinstated.